Skip to main content

WATSON 3211 WATSON 3211 Pill: brown & orange, capsule/oblong, 18mm

The pill with imprint WATSON 3211 WATSON 3211 (Brown & Orange, Capsule/Oblong, 18mm) has been identified as Rivastigmine Tartrate 6 mg and is used for Parkinson's Disease, and Alzheimer's Disease. It belongs to the drug class cholinesterase inhibitors and is not a controlled substance.

Images for WATSON 3211 WATSON 3211

Rivastigmine tartrate 6 mg WATSON 3211 WATSON 3211
Rivastigmine tartrate 6 mg WATSON 3211 WATSON 3211
Rivastigmine tartrate 6 mg WATSON 3211 WATSON 3211
Rivastigmine tartrate 6 mg WATSON 3211 WATSON 3211

Rivastigmine Tartrate

Imprint
WATSON 3211 WATSON 3211
Strength
6 mg
Color
Brown & Orange
Size
18.00 mm
Shape
Capsule/Oblong
Availability
Prescription only
Drug Class
Cholinesterase inhibitors
Pregnancy Category
B - No proven risk in humans
CSA Schedule
Not a controlled drug
Labeler / Supplier
Watson Pharmaceuticals
Inactive Ingredients
silicon dioxide, magnesium stearate, microcrystalline cellulose, gelatin, titanium dioxide, ferric oxide yellow, ferric oxide red, ferrosoferric oxide, D&C Yellow No. 10, FD&C Blue No. 1, FD&C Blue No. 2, indigotindisulfonate sodium, FD&C Red No. 40, shellac

Note: Inactive ingredients may vary.

Labelers / Repackagers

NDC Code Labeler / Repackager
00591-3211 (Discontinued) Watson Pharmaceuticals, Inc.
63739-0579 McKesson Packaging Services

Get help with Imprint Code FAQs.

See also:

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.